| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858734 Contacting a derivative of N-2-chlorobenzaldehydeylidene-1-ethylamine-2 (2-thiophenyl)imine with hydrogen cyanide source in presence of catalyst, heating; contacting with formaldehyde compund; converting a cyano group to ester |
| 02/17/2005 | WO2005015214A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005014558A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | WO2005013981A1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/17/2005 | US20050038260 Intermediate for biotin and process for producing the same |
| 02/17/2005 | US20050038088 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/17/2005 | US20050038068 Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| 02/17/2005 | US20050038053 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506204A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/10/2005 | WO2005012311A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | WO2005012310A1 Use of thienopyridine compound in perfume and novel thienopyridine compound |
| 02/10/2005 | WO2005012300A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012284A1 4,5-DIHYDRONAPHTHO[1,2-b]THIOPHENE DERIVATIVE |
| 02/10/2005 | WO2004113362A3 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | US20050033072 Photochromic diarylethene-containing coordination compounds and the production thereof |
| 02/10/2005 | US20050033052 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032778 Therapeutically active thiophenepyrimidinone compounds and their use |
| 02/10/2005 | US20050032777 benzyl carbamates and ureas such as 5-(4-(4-cyclopropylmethylpiperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5]benzodiazepine, used for treatment of sexual disorders |
| 02/10/2005 | US20050032748 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 02/10/2005 | CA2534893A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i |
| 02/10/2005 | CA2534460A1 Benzylamine derivative |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2532382A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1084269A4 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1188416C Oxathiepino [6,5-b]dihydropyridines,and related compositions and preparation methods |
| 02/08/2005 | US6852831 Alkylenedioxythiophenes and poly(alkylenedioxythiophene)s having urethane-containing side groups |
| 02/08/2005 | US6852830 Polythiophenes formed form monomers such as (2,3-dihydro-thieno(3,4-b)(1,4)dioxin-2-yl-methoxy)-acetic acid, for use as coatings, printable pastes or electroconductive layers |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/03/2005 | WO2005010063A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 02/03/2005 | WO2005010009A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | WO2005010008A1 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
| 02/03/2005 | WO2005009398A2 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/03/2005 | WO2005009387A2 Azepine derivatives as pharmaceutical agents |
| 02/03/2005 | WO2003063779A3 Selective analgesic agents |
| 02/03/2005 | US20050027122 Compounds for modulators of chemokine activity |
| 02/03/2005 | US20050026984 Such as 3-(1H-Indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-carboxylic acid benzylamide for treating a disease in a patient amenable to modulation of protein kinases; cancer, neurodegenerative disease |
| 02/03/2005 | US20050026944 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | US20050026935 Compounds |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026901 Antihistaminic spiro compounds |
| 02/03/2005 | CA2532982A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | CA2532798A1 Azepine derivatives as pharmaceutical agents |
| 02/03/2005 | CA2530281A1 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
| 02/03/2005 | CA2517260A1 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
| 02/02/2005 | EP1501838A1 A process for the preparation of clopidogrel |
| 02/02/2005 | EP1501831A1 Inhibitors of checkpoint kinases (wee1 and chk1) |
| 02/02/2005 | EP1501829A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 02/02/2005 | EP1501826A2 Substituted indoles as alpha-1 agonists |
| 02/02/2005 | EP1501822A1 Phthalazinone derivatives |
| 02/02/2005 | EP1501798A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/01/2005 | US6849738 Use as Gonadotropin releasing hormone (GnRH) antagonistic activity, and chemical intermediates; 5-(tert-aminomethyl)-1-(arylmethyl)-6-(4-(ureido)phenyl)-3-hydrocarbyl -thieno(2,3-d)pyrimidine-2,4-dione for example |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849627 Including interleukin-1 and Tumor Necrosis Factor; treating rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, septic shock, cardiopulmonary dysfunction, acute respiratory disease, and cachexia |
| 02/01/2005 | CA2193774C Process for producing 1-hydroxythienoimidazole carboxylic acid and thienoimidazole carboxylic acid |
| 01/27/2005 | WO2005007191A1 Medicinal composition |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | WO2005007083A2 Chemical compounds |
| 01/27/2005 | WO2004092181A9 Heterocyclic mchr1 antagonists |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020661 Antidiabetic agents |
| 01/27/2005 | US20050020644 Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides |
| 01/27/2005 | US20050020619 Anticancer agents ; cardiovascular disorders; antiinflammatory agents;antiarthritic agents; Crohn's diseases; antiischemic agents |